Nephros INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Nephros, Inc. announced a significant increase in net revenue and net income for the second quarter of 2026, driven by robust product sales and a favorable tariff refund.
NASDAQ
Nephros, Inc. announced a significant financial turnaround, reporting net income and positive operating cash flow for the third quarter and first nine months of 2025, driven by robust revenue growth.
NASDAQ
Nephros, Inc. reported a significant increase in net revenue and a return to net income for the second quarter and first half of 2025, driven by strong product sales and improved gross margins.
NASDAQ
Nephros, Inc. announces a profitable first quarter in 2025, driven by increased net revenue and improved gross margins compared to the same period in 2024.
NASDAQ
Nephros Inc. experienced a decrease in revenue for the third quarter of 2024, but saw improvements in gross profit margins and a return to profitability.
NASDAQ
Nephros Inc. experienced a decrease in revenue for the second quarter of 2024, primarily due to reduced emergency response orders, though programmatic sales showed growth.
NASDAQ
Nephros Inc. experienced a slight decrease in revenue for the first quarter of 2024, primarily due to reduced emergency response orders, while programmatic sales saw a 12% increase.